Adherence (adh) to and beliefs about oral anticancer medications (OAMs) in patients (pts) with metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Geynisman, Daniel M.
Hlubocky, Fay J.
Kocherginsky, Masha
Stadler, Walter Michael
Daugherty, Christopher
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Univ Chicago Med, Chicago, IL USA
[3] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA
[4] Univ Chicago, Chicago, IL 60637 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 31期
关键词：
D O I：
10.1200/jco.2013.31.31_suppl.25
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A pooled analysis of the efficacy and safety of sunitinib in elderly patients (pts) with metastatic renal cell carcinoma (mRCC).
    Hutson, T. E.
    Bukowski, R. M.
    Rini, B. I.
    Gore, M. E.
    Larkin, J. M. G.
    Figlin, R. A.
    Barrios, C. H.
    Escudier, B.
    Lin, X.
    Fly, K. D.
    Martell, B.
    Matczak, E.
    Motzer, R. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] A phase II trial of RAD001 in patients (Pts) with metastatic renal cell carcinoma (MRCC).
    Amato, R. J.
    Misellati, A.
    Khan, M.
    Chiang, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 224S - 224S
  • [23] A phase II trial of RAD001 in patients (PTS) with metastatic renal cell carcinoma (MRCC)
    Amato, R.
    Jac, J.
    Giessinger, S.
    Khan, M.
    Willis, J.
    Chiang, S.
    [J]. CANCER INVESTIGATION, 2007, 25 : 20 - 21
  • [24] Receipt of systemic therapy in older versus younger patients (pts) with metastatic renal cell carcinoma (mRCC).
    Hahn, Andrew W.
    Haaland, Ben
    Rathi, Nityam
    Dizman, Nazli
    Maughan, Benjamin Louis
    Pal, Sumanta K.
    Agarwal, Neeraj
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [25] Are there geographic differences in the outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (su)?
    Keizman, Daniel
    Ish-Shalom, Maya
    Maimon, Natalie
    Gottfried, Maya
    Pili, Roberto
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Boursi, Ben
    Weitzen, Rony
    Hayat, Henry
    Peer, Avivit
    Neumann, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Mermershtain, Wilmosh
    Roubinov, Keren
    Berger, Raanan
    Carducci, Michael Anthony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [26] Side effects of sunitinib malate (SM) treatment for patients (pts) with metastatic renal cell carcinoma (mRCC)
    Carteni, G. G.
    Montano, M.
    Perrotta, E.
    Otero, M.
    Guida, T.
    Ragone, G.
    Aurilio, G.
    Maiorino, L.
    Stavolo, C.
    Panza, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Immune cell changes in the peripheral blood of metastatic renal cell carcinoma (mRCC) patients (pts) treated with sunitinib or temsirolimus
    Salas, R. N.
    Ireland, J. L.
    Ko, J. S.
    Elson, P.
    Garcia, J. A.
    Wood, L.
    Bukowski, R. M.
    Rini, B. I.
    Finke, J. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] Association of tumor burden characteristics with outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib
    Golshayan, A. R.
    Elson, P.
    Wood, L. S.
    Garcia, J. A.
    Dreicer, R.
    Rini, B. I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Patterns of treatment (trx) with angiogenesis inhibitors (AIs) in patients (pts) with metastatic renal cell carcinoma (mRCC) in France
    Levy, A.
    Gross-Goupil, M.
    Sarda, S. P.
    Korves, C.
    Antras, L.
    Luka, A.
    Ramamurthy, P.
    Neary, M.
    Duh, M. S.
    Escudier, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] A pilot study of tremelimumab (treme) with or without cryoablation (cryo) in patients (pts) in metastatic renal cell carcinoma (mRCC)
    Campbell, M. T.
    Martin, S.
    Tam, A. L.
    Sheth, R. A.
    Singh, S.
    Ahrar, K.
    Tidwell, B. Slack
    Rao, P.
    Karam, J. A.
    Wood, C. G.
    Tannir, N. M.
    Jonasch, E.
    Gao, J.
    Shah, A. Y.
    Blando, J. M.
    Duan, F.
    Basu, S.
    Allison, J.
    Sharma, P.
    Singh, S.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
12345